Aerie Pharmaceuticals, Inc. First Quarter 2021 Earnings Call | Aerie Pharmaceuticals, Inc

Skip to main navigation

About Us
Careers
- Working at Aerie
Contact
- General Inquiries
DISCOVaerie™ Live!
- Overview

Search:

About Us
Products
R&D
Investors
Careers
- Working at Aerie
Contact
- General Inquiries

Investors

Investor Relations

FAQs
News & Presentations
- News Releases
- Events & Presentations
Stock Information
Reports & Filings
Corporate Governance
Our Leadership
Our Board of Directors
Contact Us
Sign up for email alerts

Aerie Pharmaceuticals, Inc. First Quarter 2021 Earnings Call

May 5, 2021 at 5:00 PM EDT

Listen to webcast

PRODUCTS Overview Rhopressa^® Rocklatan^® DISCOVaerie™ Live! R&D Pipeline Glaucoma Ocular Surface Disease - AR-15512 Retinal Disease - AR-1105 Implant - AR-13503 SR Implant - AR-14034 SR Implant Clinical Trials Research Bibliography Investigator Initiated Research Medical Affairs

INVESTORS FAQs News & Presentations Stock Information Reports & Filings Corporate Governance Our Leadership Our Board of Directors Contact Us

ABOUT US Our Scientific Heritage Aerie At-a-Glance Our Leadership Our Board of Directors Our ESG Commitment CAREERS Working at Aerie CONTACT General Inquiries

Corporate Headquarters

4301 Emperor Blvd

Suite 400

Durham, NC 27703

Tel. +1 919-237-5300

Aerie Pharmaceuticals, Inc.
©2021 All Rights Reserved. This site intended for U.S. audiences only.

Terms of Use
Privacy Policy
Site Map

TOP